Please login to the form below

Not currently logged in
Email:
Password:

Leo Pharma calls in Waggener Edstrom

Agency will drive awareness of the pharma company’s anticoagulant in the German market

Leo Pharma has appointed Waggener Edstrom to help drive awareness of its anticoagulant Innohep (tinzaparin) in the German market.

The Munich offices of the communications agency won the account following a competitive pitch process, with the pharma company citing a compelling campaign proposal as a determining factor.

"We are very proud to win an account with a prestigious company like Leo Pharma," said Manuel Hüttl, VP and general manager of Waggener Edstrom Worldwide, Germany, Austria and Switzerland.

"We are looking forward to supporting the Leo Pharma team with the development and execution of innovative, creative and bold strategies."

Since the acquisition of healthcare comms agency Patzer PR in 2012, Waggener Edstrom has been adding names to its list of pharma clients, which includes Astellas, 3M Espe, Berlin Chemie, Medice, AOK Baden-Württemberg and now Leo Pharma.

11th March 2013

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Langland

Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...